This company has been acquired
Tabula Rasa HealthCare Beheer
Beheer criteriumcontroles 3/4
Tabula Rasa HealthCare's CEO is Brian Adams, appointed in Sep 2022, has a tenure of 1.17 years. total yearly compensation is $2.30M, comprised of 19.6% salary and 80.4% bonuses, including company stock and options. directly owns 1.55% of the company’s shares, worth $4.40M. The average tenure of the management team and the board of directors is 2.5 years and 5 years respectively.
Belangrijke informatie
Brian Adams
Algemeen directeur
US$2.3m
Totale compensatie
| Percentage CEO-salaris | 19.6% |
| Dienstverband CEO | 1.2yrs |
| Eigendom CEO | 1.5% |
| Management gemiddelde ambtstermijn | 2.5yrs |
| Gemiddelde ambtstermijn bestuur | 5yrs |
Recente managementupdates
Recent updates
Continuing To Avoid Tabula Rasa HealthCare Inc.
May 19Does Tabula Rasa HealthCare (NASDAQ:TRHC) Have A Healthy Balance Sheet?
May 11
Is Tabula Rasa HealthCare (NASDAQ:TRHC) Using Too Much Debt?
Feb 09Calculating The Fair Value Of Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC)
Jan 19Why Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) Could Be Worth Watching
Dec 06Is Tabula Rasa HealthCare (NASDAQ:TRHC) A Risky Investment?
Nov 05Tabula Rasa HealthCare, Inc.'s (NASDAQ:TRHC) Intrinsic Value Is Potentially 84% Above Its Share Price
Jul 26Is Tabula Rasa HealthCare (NASDAQ:TRHC) Using Too Much Debt?
Jun 28We Discuss Why Tabula Rasa HealthCare, Inc.'s (NASDAQ:TRHC) CEO Compensation May Be Closely Reviewed
Jun 05Tabula Rasa HealthCare, Inc. 2021 Q1 - Results - Earnings Call Presentation
May 07Tabula Rasa HealthCare, Inc.'s (NASDAQ:TRHC) Intrinsic Value Is Potentially 60% Above Its Share Price
Apr 02Tabula Rasa HealthCare (NASDAQ:TRHC) Is Carrying A Fair Bit Of Debt
Mar 12Update: Tabula Rasa HealthCare (NASDAQ:TRHC) Stock Gained 51% In The Last Three Years
Feb 19Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2023 | n/a | n/a | -US$61m |
| Mar 31 2023 | n/a | n/a | -US$64m |
| Dec 31 2022 | US$2m | US$450k | -US$77m |
| Sep 30 2022 | n/a | n/a | -US$72m |
| Jun 30 2022 | n/a | n/a | -US$58m |
| Mar 31 2022 | n/a | n/a | -US$59m |
| Dec 31 2021 | US$2m | US$403k | -US$52m |
| Sep 30 2021 | n/a | n/a | -US$70m |
| Jun 30 2021 | n/a | n/a | -US$80m |
| Mar 31 2021 | n/a | n/a | -US$80m |
| Dec 31 2020 | US$2m | US$385k | -US$57m |
| Sep 30 2020 | n/a | n/a | -US$57m |
| Jun 30 2020 | n/a | n/a | -US$44m |
| Mar 31 2020 | n/a | n/a | -US$36m |
| Dec 31 2019 | US$3m | US$408k | -US$32m |
| Sep 30 2019 | n/a | n/a | -US$36m |
| Jun 30 2019 | n/a | n/a | -US$18m |
| Mar 31 2019 | n/a | n/a | -US$40m |
| Dec 31 2018 | US$2m | US$408k | -US$47m |
| Sep 30 2018 | n/a | n/a | -US$26m |
| Jun 30 2018 | n/a | n/a | -US$30m |
| Mar 31 2018 | n/a | n/a | -US$3m |
| Dec 31 2017 | US$882k | US$328k | US$13m |
| Sep 30 2017 | n/a | n/a | -US$3m |
| Jun 30 2017 | n/a | n/a | -US$8m |
| Mar 31 2017 | n/a | n/a | -US$7m |
| Dec 31 2016 | US$2m | US$278k | -US$3m |
Compensatie versus markt: Brian's total compensation ($USD2.30M) is above average for companies of similar size in the US market ($USD1.53M).
Compensatie versus inkomsten: Brian's compensation has been consistent with company performance over the past year.
CEO
Brian Adams (41 yo)
1.2yrs
Tenure
US$2,301,712
Compensatie
Mr. Brian W. Adams serves as President at Tabula Rasa HealthCare, Inc since September 14, 2022. He served as Vice President of Finance at CareKinesis, Inc. since October 2011 until 2014. He had been Co-Pre...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO, President & Director | 1.2yrs | US$2.30m | 1.55% $ 4.4m | |
| Chief Financial Officer | 1.8yrs | US$1.46m | 0.41% $ 1.2m | |
| COO & President of Pharmacy Services | 9.4yrs | US$1.86m | 1.2% $ 3.4m | |
| VP, Corporate Controller & Chief Accounting Officer | less than a year | geen gegevens | 0.037% $ 105.0k | |
| Chief Technology Officer | 3.3yrs | geen gegevens | geen gegevens | |
| Chief Administrative Officer | 8.8yrs | geen gegevens | geen gegevens | |
| Senior Vice President of Investor Relations & Corporate Development | 3.7yrs | geen gegevens | geen gegevens | |
| Chief Legal Officer & Corporate Secretary | less than a year | geen gegevens | geen gegevens | |
| Chief People Officer | 1.8yrs | geen gegevens | geen gegevens | |
| Chief of Staff | less than a year | geen gegevens | geen gegevens | |
| Chief of Staff | 5.5yrs | geen gegevens | geen gegevens | |
| Senior Vice President of Healthcare Analytics | 5.5yrs | geen gegevens | geen gegevens |
2.5yrs
Gemiddelde duur
55yo
Gemiddelde leeftijd
Ervaren management: TRHC's management team is considered experienced (2.5 years average tenure).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| CEO, President & Director | less than a year | US$2.30m | 1.55% $ 4.4m | |
| Independent Director | 1.2yrs | US$257.50k | 0.29% $ 823.1k | |
| Independent Director | 6.7yrs | US$235.53k | 0.41% $ 1.2m | |
| Member of Strategic Advisory Board | no data | geen gegevens | geen gegevens | |
| Member of Strategic Advisory Board | no data | geen gegevens | geen gegevens | |
| Member of Strategic Advisory Board | no data | geen gegevens | geen gegevens | |
| Independent Board Chairman | 5.3yrs | US$257.78k | 0.52% $ 1.5m | |
| Independent Director | 6.3yrs | US$239.47k | 0.33% $ 927.1k | |
| Independent Director | 4.7yrs | US$229.67k | 0.33% $ 934.6k | |
| Independent Director | 5yrs | US$231.33k | 0.17% $ 488.5k | |
| Member of Strategic Advisory Board | no data | geen gegevens | geen gegevens | |
| Member of Strategic Advisory Board | no data | geen gegevens | geen gegevens |
5.0yrs
Gemiddelde duur
62.5yo
Gemiddelde leeftijd
Ervaren bestuur: TRHC's board of directors are considered experienced (5 years average tenure).